Thursday, March 05, 2026

Study challenges perception of transgender women’s advantages in sports, faces methodological criticism

February 5, 2026
2 mins read
Study challenges perception of transgender women's advantages in sports, faces methodological criticism

New study claims transgender women lack athletic advantage

A controversial new study from Brazilian researchers asserts that transgender women do not hold any inherent physical edge over biological females in athletic competition, reports BritPanorama.

The research, conducted by scientists at the University of Sao Paulo and published in the British Journal of Sports Medicine, examined strength, fitness levels, and body composition among transgender individuals receiving hormone therapy compared with cisgender counterparts. Drawing on 52 separate studies encompassing more than 5,000 transgender participants and over 1,000 women aged 14 to 41, the analysis found that while trans women retained greater lean mass after hormonal treatment, their overall physical fitness was “comparable” to other women.

The researchers concluded their findings “do not justify blanket bans” on transgender women participating in female sport. However, the study has drawn sharp criticism from academics who argue it suffers from significant methodological shortcomings.

Professor Alun Williams, who specialises in sport and exercise genomics at Manchester Metropolitan University, contends that the research failed to monitor fitness levels over time or before hormone treatment commenced. He argues it is “almost worthless to compare groups without tight assessment of training history”.

Williams also highlighted that hormonal intervention following puberty cannot alter skeletal structure, including height, limb length, and shoulder width. “Those advantages to men in many sports remain in transgender women regardless of hormone changes,” he said, adding that he does not agree with the authors that the studies published to date overturn the evidence for inherent athletic advantage in transgender women.

The Brazilian study’s conclusions contrast sharply with earlier research in this field. A 2022 study demonstrated that male-to-female transitioners remained faster, stronger, and more physically capable than most women even after undergoing hormone treatment. The authors of the new research acknowledge their evidence was of mixed quality and lacked diversity in age groups, sporting disciplines, and competitive levels.

They also concede that most studies included in their analysis did not feature elite-level athletes. “Although the current data do not justify blanket bans, critical gaps in literature were found, notably the underrepresentation of transgender athletes who may retain more ‘muscle memory’,” the researchers wrote.

The study is being criticised by both academics and sex-based rights organisations for flaws in its methodology. Following last year’s Supreme Court ruling that the legal definition of a woman under the Equality Act is based on biological sex, numerous UK sporting bodies prohibited transgender women from competing in female categories, including cricket and football. Fiona McAnena, director of campaigns at Sex Matters, dismissed the study’s conclusions, stating, “Men do not shrink or magically lose all their male advantages when they identify as women, no matter what hormones they take.”

Dr Blair Hamilton, a research associate at Manchester Metropolitan University, offered a more measured response, stating the findings were “consistent with what we’ve seen in the wider scientific literature”. However, Dr Hamilton cautioned that understanding the impact on elite competition requires studying elite athletes, noting “there are very few openly transgender elite athletes anywhere in the world”.

As the debate continues, it highlights the complexity surrounding gender identity in sports and the importance of evidence in guiding policy decisions.

Leave a Reply

Your email address will not be published.

Don't Miss

Aryna Sabalenka criticizes transgender athletes' participation in women's tennis as unfair

Aryna Sabalenka criticizes transgender athletes’ participation in women’s tennis as unfair

Aryna Sabalenka speaks out against transgender women in tennis Women’s world number
FDA removes black box warning on hormone therapy, citing new evidence and benefits for menopausal women

FDA removes black box warning on hormone therapy, citing new evidence and benefits for menopausal women

On Monday, U.S. Health and Human Services Secretary Robert F. Kennedy Jr.